Business
Outset Medical to Present Research Highlighting Home Hemodialysis Success for Underserved Populations at National Kidney Foundation Spring Clinical Meetings
Abstracts include results of innovative home hemodialysis program in Hawaii and gender gap survey focused on female nephrologists SAN JOSE, Calif.--(BUSINESS
About this update from Outset Medical, Inc.
[{"type":"text","content":"\nAbstracts include results of innovative home hemodialysis program in Hawaii and gender gap survey focused on female nephrologists\n\n\n SAN JOSE, Calif.--(BUSINESS WIRE)--\nOutset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of dialysis with its Tablo® Hemodialysis System, is presenting five new abstracts providing promising insights on the clinical and financial benefits of home hemodialysis (HHD), gender biases toward female nephrologists and other pertinent topics related to kidney disease.\n\n\n“Kidney disease is debilitating and takes away the freedom of choice for patients,” said Leslie Trigg, Chair and Chief Executive Officer of Outset. “But we are changing the lens with which we look at dialysis. This research solidifies that all patients deserve access to options such as home hemodialysis regardless of health disparities and environmental conditions.”\n\n\nThe research will be presented at the National Kidney Foundation (NKF) Spring Clinical Meetings (SCM23) in Austin, TX, which run from April 11-15. Kidney professionals from around the world will attend this event to learn about new developments in nephrology.\n\n\n“Our latest studies demonstrate how Outset is working to bring innovation to the dialysis industry by overcoming the bias that chronic kidney disease (CKD) patients need perfect conditions to treat at home,” said Michael Aragon, MD, Chief Medical Officer for Outset. “One example is the successful implementation of Tablo in a program for an underserved population in Hawaii that overcame the challenges of environmental barriers and other health factors, resulting in a high treatment success rate.”\n\n\nThe following abstracts will be presented at the NKF SCM23:\n\n\nRedefining Dialysis Care on the Hawaiian Islands: Reducing Health Disparities and Resource Utilization — An HHD program implemented on the islands of Maui, Hawaii and Oahu where Tablo was provided for End-Stage Kidney Disease (ESKD) care under challenging environmental conditions and among a population with the highest rates of diabetes, coronary artery disease and kidney disease of any racial group. Use of Tablo among this population resulted in a high treatment success rate even given the less than ideal home environments and patients with health disparities.\n\n\nThe Transition from Perit...